← Open Payments lookup

INNA KIGEL: Open Payments

NPI 1235210956 · KEW GARDENS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,557 in 81 payments from 15 companies in 2025. Trend: 2023 $2,406 · 2024 $2,045 · 2025 $1,557

Food & beverage: $1,557
CompanyPaymentsAmount
GlaxoSmithKline, LLC.18$250
AstraZeneca Pharmaceuticals LP10$233
ABBVIE INC.11$227
Boehringer Ingelheim Pharmaceuticals, Inc.9$198
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$195
Novo Nordisk Inc5$126
Gilead Sciences, Inc.4$81
Sumitomo Pharma America, Inc.2$48
Lilly USA, LLC2$43
Takeda Pharmaceuticals U.S.A., Inc.2$41

Products named: TRELEGY ELLIPTA, JARDIANCE, XIFAXAN, AIRSUPRA, FARXIGA, CREON, QULIPTA, Ozempic.

Industry payments across NY — which companies pay providers there.